Merindol, France

Joseph Duvochel

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ethypharm, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Duvochel. Retrieved from https://idiyas.com/inventor/joseph-duvochel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Duvochel: Innovator in Pharmaceutical Technology

Introduction

Joseph Duvochel is a notable inventor based in Mérindol, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of medications.

Latest Patents

Joseph Duvochel holds a patent for a sublingual coated tablet of fentanyl. This invention relates to a fentanyl-coated tablet and the method for its preparation. The patent represents a significant advancement in pain management, providing a more effective way to administer this potent analgesic.

Career Highlights

Duvochel is associated with Ethypharm, Inc., a company known for its commitment to developing innovative pharmaceutical solutions. His work at Ethypharm has allowed him to contribute to various projects aimed at improving patient outcomes through advanced drug formulations.

Collaborations

Throughout his career, Joseph has collaborated with several talented professionals, including Pascal Oury and Guillaume Benoist. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Joseph Duvochel's contributions to pharmaceutical technology exemplify the impact of innovation in healthcare. His work continues to influence the development of effective drug delivery systems, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…